Recruiting

Vascular Access Devices

Sponsor:

Teleflex

Code:

NCT06604039

Conditions

Vascular Access Device

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

Central venous catheter

Study Details

Brief summary:

The general objective of Teleflex's Vascular Access Device Registry (VADER) is to provide high-quality Level 3 (or better) data on the performance, safety and clinical benefits of Teleflex's vascular access devices when used in a real-world setting

Conditions

Vascular Access Device

Study ID

NCT06604039

Start date

Dec 8, 2024

Status verified date

Aug, 2026

Completion date

Dec 7, 2034

Anticipated

Primary completion date

Dec 7, 2034

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Subjects will undergo a procedure that will include use of a Teleflex device covered by this Research.
  • Subject is willing and capable of providing informed consent and/or give approval to collect, store and process limited health information by the Sponsor; or such consent is provided by a legally designated representative if required by local law or regulation.
  • Subjects is able to read and understand English or Spanish languages

Exclusion Criteria:

  • Subject is currently participating in another clinical Registry or investigation that may confound the results of this Registry.
  • Subject was previously failed screening or was enrolled in this clinical Registry.
  • Subject is imprisoned
  • Subject is cognitively impaired and unable to provide informed consent

Study Design

Enrollment

2500 participants

Anticipated

Interventions and Outcome Measures

Arms

Subject

Needing a vascular access device for therapy or diagnosis

Interventions

Central venous catheter

Placement of a medical device to gain entry into the bloodstream, typically through a vein or artery, for the purpose of administering fluids, medications, blood products, or for hemodialysis

Primary outcome measure

  • Catheter devices: successful use of the device without removal due to device-related adverse events [ Time Frame: Within 7 days after subject device removal ]
  • Arrow VPS Rhythm DXL catheter tip positioning system: Successful verification of catheter tip location [ Time Frame: Immediately after subject device removal ]

Central Contacts and Locations

Central contacts

Samson Odeyemi

9402904684samson.odeyemi@teleflex.com

Maame E. Sekyere

3014012791maame.sekyere@teleflex.com

Locations

Huntsville Hospital

Recruiting

Huntsville, Alabama, United States, 35801

Contacts

Sara Couey, DNP, CRNP

sara.couey@hhsys.org

Loma Linda University Health

Recruiting

Loma Linda, California, United States, 92354

Contacts

Melissa McCabe, MD, MSCR

mmccabe@llu.edu

Sarah Capalla, MSN, RN

scapalla@llu.edu

Tufts Medical Center

Recruiting

Boston, Massachusetts, United States, 02111

Contacts

Haval Chweich, MD

haval.chweich1@tuftsmedicine.org

More Information

Sponsor

Teleflex

Last update posted

Aug 11, 2026

Last verified

Aug, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Teleflex on 2026-08-11.